Marco Bregni - Concepedia

Author

Marco Bregni

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

C Miano, C Peters, Dietger Niederwieser, Giovanni Bozza, H Baldomero, M Bregni, M Danova, M. Bregni, M.B. Bregni, MARCO BREGNI

335

Publications

16.3K

Citations

H-Index

104

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Vita-Salute San Raffaele University University of Milan Istituti di Ricovero e Cura a Carattere Scientifico Ospedale di Circolo di Busto Arsizio

About

Marco Bregni is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	59	8.8K
2	Health Sciences	11	15	836
3	Engineering	2	2	204
4	Allergy	2	2	46
5	Natural Sciences	1	1	19

Marco Bregni

118

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma Lorena Appio, Carlo Landoni, Maria La Targia, Chemotherapy Cell TherapyImmunologyImmunotherapyCancer ChemotherapyTranslational Medicine	2017	2.3K
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Riccardo Dalla‐Favera, Marco Bregni, J Erikson, Proceedings of the National Academy of Sciences Complete GeneGeneticsImmunologyPathologyBurkitt Lymphoma Cells	1982	1.8K
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency Alessandro Aiuti, Federica Cattaneo, Stefania Galimberti, New England Journal of Medicine	2009	997
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION AlessandroM. Gianni, Marco Bregni, A. Stern, The Lancet TransplantationMarrow TransplantationStem Cell MobilizationStem Cell TransplantationImmunology	1989	750
Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor Salvatore Siena, Marco Bregni, Bruno Brando, Blood	1989	537
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients Salvatore Siena, Marco Bregni, Bruno Brando, Blood	1991	511
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study Fabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, The Lancet Oncology Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunology	2009	481
High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma Alessandro M. Gianni, Marco Bregni, Salvatore Siena, New England Journal of Medicine	1997	478
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 Per Ljungman, Marco Bregni, Mats Brune, Bone Marrow Transplantation TransplantationAutoimmune DiseaseSolid Organ TransplantationEurope 2009Immunology	2009	384
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses Eduardo J. Villablanca, Laura Raccosta, Dan Zhou, Nature Medicine Tumor BiologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2009	327

Page 1